Initial public issue of up to 22,41,000 equity shares of face value of Rs.10/- each (the "Equity Shares") of Asston Pharmaceuticals Limited ("the Company" or "APL" or "the Issuer") at an issue price of Rs. 123 per equity share for cash, aggregating up to Rs. 27.56 crores ("Public Isue") out of which upto 1,13,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 123 per equity share for cash, aggregating Rs. 1.39 crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of upto 21,28,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 123 per equity share for cash, aggregating upto Rs. 26.17 crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute 26.33 % and 25 %, respectively of the post-issue paid-up equity share capital of the company.
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
09-Jul-2025
11-Jul-2025
₹ 123.00
₹ 0.00
Minimum Application for shares in Nos : 2000.0
Further Multiples of : 1000.0
(₹)Cr.
Lead Managers to the Issue
Project Cost
23.95
Sobhagya Capital Options Pvt. Ltd.
Project Financed through Current Offer
27.56
Post Issue Equity Share Capital
8.51
Issue Price
₹123.00
Projects
Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
Funding the incremental working capital requirements of our company
Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our company.